Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
adipose-derived mesenchymal stem cell injection
- Development stage
- Unknown
- Lead developer
- Guangdong Sail Biological Technology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Adipose-derived mesenchymal stem cell injection is a cell therapy product consisting of multipotent stromal cells isolated from adipose tissue and expanded in vitro. Developed by Guangdong Sail Biological Technology, this therapeutic is being investigated for the treatment of type 2 diabetes mellitus (T2DM). The mechanism of action involves the secretion of paracrine factors and cytokines that exert immunomodulatory and anti-inflammatory effects, which are intended to reduce systemic insulin resistance and protect pancreatic beta-cell function. In clinical settings, the product is administered via intravenous injection, often in single or repeated weekly doses, to patients whose diabetes is inadequately controlled by intensive insulin therapy and who are at high risk for cardiovascular or renal complications.
- Other names
- AD-MSCsadipose-derived MSCsadipose-derived mesenchymal stem cells脂肪间充质干细胞注射液
Beyond the preview
Go deeper on adipose-derived mesenchymal stem cell injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on adipose-derived mesenchymal stem cell injection.